Traws Pharma
TRAW
TRAW
34 hedge funds and large institutions have $6.14M invested in Traws Pharma in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 2 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
39% less capital invested
Capital invested by funds: $10.1M → $6.14M (-$3.95M)
83% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 12
Holders
34
Holding in Top 10
–
Calls
$176K
Puts
$49K
Top Buyers
| 1 | +$753K | |
| 2 | +$370K | |
| 3 | +$341K | |
| 4 |
Two Sigma Investments
New York
|
+$173K |
| 5 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
+$118K |
Top Sellers
| 1 | -$958K | |
| 2 | -$575K | |
| 3 | -$493K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$465K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$191K |